Vir Biotechnology, Inc.
VIR
$5.63
-$0.44-7.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -499.65M | -550.23M | -577.65M | -521.96M | -533.34M |
| Total Depreciation and Amortization | 11.67M | 11.57M | 12.91M | 14.56M | 16.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.05M | 79.72M | 124.78M | 144.37M | 149.62M |
| Change in Net Operating Assets | -36.60M | 1.49M | 24.88M | -83.32M | -99.07M |
| Cash from Operations | -453.54M | -457.45M | -415.08M | -446.35M | -466.64M |
| Capital Expenditure | -6.89M | -9.34M | -7.47M | -7.71M | -6.84M |
| Sale of Property, Plant, and Equipment | 2.82M | 2.79M | 3.12M | 3.37M | 917.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 368.53M | 449.17M | 602.12M | 503.71M | 259.74M |
| Cash from Investing | 364.46M | 442.61M | 597.77M | 499.37M | 253.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 178.00K | 178.00K | 247.00K | 178.00K | 200.00K |
| Issuance of Common Stock | 4.36M | 4.33M | 4.93M | 4.55M | 5.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -524.00K | -565.00K | -343.00K | -343.00K | -465.00K |
| Cash from Financing | 4.01M | 3.94M | 4.83M | 4.39M | 4.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -85.07M | -10.90M | 187.52M | 57.40M | -208.02M |